Literature DB >> 14618252

The HIV-1 Vif protein: a paradigm for viral:cell interactions.

R J Pomerantz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14618252     DOI： 10.1007/s00018-003-3192-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  9 in total

1.  Parvovirus B19 genome in endomyocardial biopsy specimen.

Authors:  Sabine Pankuweit; Steffen Lamparter; Michael Schoppet; Bernhard Maisch
Journal:  Circulation       Date:  2004-04-13       Impact factor: 29.690

2.  Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Chandra Bomma; Darshan Dalal; Harikrishna Tandri; Kalpana Prakasa; Khurram Nasir; Ariel Roguin; Jonathan Piccini; Jun Dong; Mahesh Mahadevappa; Crystal Tichnell; Cynthia James; Joao A C Lima; Elliot Fishman; Hugh Calkins; David A Bluemke
Journal:  Am J Cardiol       Date:  2007-05-21       Impact factor: 2.778

4.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

5.  Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study.

Authors:  Harikrishna Tandri; Robson Macedo; Hugh Calkins; Frank Marcus; David Cannom; Melvin Scheinman; James Daubert; Mark Estes; David Wilber; Mario Talajic; Henry Duff; Andrew Krahn; Michael Sweeney; Hasan Garan; David A Bluemke
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

6.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1.

Authors:  Giorgia Beffagna; Gianluca Occhi; Andrea Nava; Libero Vitiello; Andrea Ditadi; Cristina Basso; Barbara Bauce; Gianni Carraro; Gaetano Thiene; Jeffrey A Towbin; Gian Antonio Danieli; Alessandra Rampazzo
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

7.  A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14.

Authors:  G M Severini; M Krajinovic; B Pinamonti; G Sinagra; P Fioretti; M C Brunazzi; A Falaschi; F Camerini; M Giacca; L Mestroni
Journal:  Genomics       Date:  1996-01-15       Impact factor: 5.736

8.  The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24.

Authors:  A Rampazzo; A Nava; G A Danieli; G Buja; L Daliento; G Fasoli; R Scognamiglio; D Corrado; G Thiene
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

Review 9.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Gaetano Thiene; Domenico Corrado; Cristina Basso
Journal:  Orphanet J Rare Dis       Date:  2007-11-14       Impact factor: 4.123
  9 in total
  2 in total

Review 1.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

2.  Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

Authors:  Xiaodan Wang; Xiaoying Wang; Haihong Zhang; Mingyu Lv; Tao Zuo; Hui Wu; Jiawen Wang; Donglai Liu; Chu Wang; Jingyao Zhang; Xu Li; Jiaxin Wu; Bin Yu; Wei Kong; Xianghui Yu
Journal:  Retrovirology       Date:  2013-08-29       Impact factor: 4.602
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.